Roche Unveils Elecsys IGRA SARS-CoV-2 Test In Countries That Accept CE Mark

Swiss drug major Roche Holding AG (RHHBY) announced Monday the launch of the Elecsys IGRA SARS-CoV-2 test in countries that accept the CE Mark.

The Elecsys IGRA SARS-CoV-2 test is intended as an aid in identifying individuals with an adaptive T-cell response to SARS-CoV-2, which is indicative of past exposure to the virus or COVID-19 vaccination.

The test combines in vitro T-cell stimulation, using SARS-CoV-2 antigens in the cobas IGRA SARS-CoV-2 Tubes developed in cooperation with LG Chem Life Sciences, a business division within LG Chem, and an automated electrochemiluminescence immunoassay or ECLIA for interferon gamma to qualitatively detect T cell-mediated immune response to SARS-CoV-2 in human whole blood.

The test supports the better understanding of immune response to SARS-CoV-2 infection and vaccination. It will be an additional tool to make better-informed decisions around care, sanitary measures and treatment options.

According to the company, there is increasing evidence that measuring the complementary T-cell response may play an important role in determining the overall protection level achieved.

Thomas Schinecker, CEO of Roche Diagnostics, said, "The Elecsys IGRA SARS-CoV-2 test can provide a deeper understanding into immune response. This in turn may help to understand and identify those at higher risk of progressing to severe disease during an existing or future infection. This is particularly important in immunocompromised and high-risk patient groups that represent up to 20% in a given population. The test results can help healthcare professionals to provide them with long-term guidance like appropriate treatment."

For More Such Health News, visit rttnews.com

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Ride-hailing and delivery platform Uber Technologies, Inc. reported Wednesday weak profit in its fourth quarter, while adjusted EBITDA surged from last year with strong revenue growth above market view. Gross bookings increased and the company projects higher gross bookings in the first quarter. Nelson Chai, CFO, said the company significantly exceeded profitability outlook in 2022, ... Societe Generale Group reported Wednesday a weak profit in its fourth quarter, despite higher net banking income. Further, the French Financial services major proposed a dividend and around 440 million euros share buyback program. The company also confirmed fiscal 2025 financial targets. City of Industry, California-based Titans Global Inc. is recalling certain JSJ branded cakes citing potential to contain undeclared eggs, a known allergen, the U.S. Food and Drug Administration said. The recall involves its 95g packages of JSJ Chocolate Cake, JSJ ZSR Cake, and JSJ DMC Leaf Cake food treats.
Follow RTT